Icad Z Score

ICAD
 Stock
  

USD 1.67  0.01  0.60%   

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Please see Icad Piotroski F Score and Icad Valuation analysis.
  
Icad Invested Capital Average is projected to increase significantly based on the last few years of reporting. The past year's Invested Capital Average was at 8.11 Million. The current year Working Capital is expected to grow to about 38.1 M, whereas Return on Invested Capital is forecasted to decline to (1.48) . Icad Research and Development Expense is projected to increase significantly based on the last few years of reporting. The past year's Research and Development Expense was at 9.19 Million. The current year Weighted Average Shares is expected to grow to about 26.7 M, whereas Consolidated Income is forecasted to decline to (12.1 M).

Icad Z Score Analysis

Icad's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2019 2020 2021 2022 (projected)
Interest Expense784 K476 K141 K144.71 K
Gross Profit24.23 M21.35 M24.24 M22.32 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Icad Z Score

    
  2.8  
Most of Icad's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Icad Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Icad is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Icad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icad's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

According to the company's disclosures, Icad Inc has a Z Score of 2.8. This is 58.52% lower than that of the Health Care Technology sector and 35.48% lower than that of the Health Care industry. The z score for all United States stocks is 67.89% higher than that of the company.

Icad Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.
Icad is currently under evaluation in z score category among related companies.

Icad Current Valuation Drivers

We derive many important indicators used in calculating different scores of Icad from analyzing Icad's financial statements. These drivers represent accounts that assess Icad's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icad's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(119.8 K)(92.96 K)(98.2 K)(154.05 K)(82.08 K)(88.56 K)
Revenue Per Employee236.15 K264.13 K227.1 K259.8 K245.53 K282.52 K
Average Assets35.47 M29.1 M39.29 M47.28 M67.5 M58.43 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(13.17 M)(8.26 M)(12.9 M)(16.98 M)(10.79 M)(11.64 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(12.66 M)(7.76 M)(12.05 M)(16.52 M)(10.55 M)(11.38 M)
Earnings before Tax(14.27 M)(8.97 M)(13.51 M)(17.57 M)(11.24 M)(12.13 M)
Average Equity20.56 M9.72 M7.18 M24.36 M50.18 M39.66 M
Enterprise Value51.51 M61.34 M153.32 M290.71 M146.27 M137.29 M
Free Cash Flow(7.73 M)(4.17 M)(7.4 M)(7.45 M)(9.97 M)(10.23 M)
Invested Capital6.36 M9.5 M20.54 M11.15 M4.79 M6.34 M
Invested Capital Average3.29 M5.82 M16.51 M10.77 M8.11 M8.2 M
Market Capitalization56.8 M62.06 M150.42 M303.51 M180.79 M160.4 M
Tangible Asset Value21.84 M21.82 M32.2 M46.33 M53.15 M45.72 M
Working Capital9.14 M7.97 M10.36 M25.55 M35.34 M38.13 M

Icad Fundamentals

About Icad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Icad Piotroski F Score and Icad Valuation analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
44.3 M
Quarterly Revenue Growth YOY
(0.32) 
Return On Assets
(0.15) 
Return On Equity
(0.34) 
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.